Investor Alert

New York Markets Close in:

Market Snapshot Winners and Losers

GW Pharmaceuticals PLC ADR

NAS: GWPH

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
GW Pharmaceuticals PLC ADR

Market open

 --Real time quotes

Sep 18, 2020, 12:17 p.m.

GWPH
/zigman2/quotes/209686240/composite

$

100.29

Change

-1.72 -1.69%

Volume

Volume 273,249

Real time quotes

/zigman2/quotes/209686240/composite

Previous close

$ 102.01

$ 100.29

Change

-1.72 -1.69%

Day low

Day high

$99.72

$102.16

Open

52 week low

52 week high

$67.98

$141.98

Open
Income Statement Balance Sheet Cash Flow Statement

Annual Financials for GW Pharmaceuticals PLC ADR

View Ratios
Fiscal year is January-December. All values USD millions. 20152016201720182019 5-year trend
Sales/Revenue 44.01M14.58M10.58M15.49M312.62M
Cost of Goods Sold (COGS) incl. D&A 7.42M9.03M11.64M11.01M27.31M
COGS excluding D&A 3.87M3.84M4.55M1.63M18.03M
Depreciation & Amortization Expense 3.55M5.18M7.09M9.38M9.28M
Depreciation 3.47M5.1M6.78M8.49M8.03M
Amortization of Intangibles 80,19187,661314,865892,8881.25M
Gross Income 36.59M5.56M(1.06M)4.48M285.31M
20152016201720182019 5-year trend
SG&A Expense 133.48M164.13M188.8M278.63M408.23M
Research & Development 114.09M141.13M142.87M133.49M147.28M
Other SG&A 19.38M23.01M45.93M145.14M260.96M
Other Operating Expense -----
Unusual Expense 934,531-536,177--
EBIT after Unusual Expense (97.82M)-(536,177)--
Non Operating Income/Expense 9.56M36.13M(6.48M)(2.13M)102.27M
Non-Operating Interest Income 376,280859,6392.08M8.91M8.5M
Equity in Affiliates (Pretax) -----
Interest Expense 115,660244,601956,6681.26M1.09M
Gross Interest Expense 115,660244,601956,6681.26M1.09M
Interest Capitalized -----
Pretax Income (88M)(121.84M)(195.76M)(268.62M)(13.25M)
Income Tax (19.27M)(31.83M)(26.61M)4.07M(4.19M)
Income Tax - Current Domestic --2.15M4.06M-
Income Tax - Current Foreign 564,4201.66M--9.55M
Income Tax - Deferred Domestic (89,444)(2.82M)(3.2M)8,785-
Income Tax - Deferred Foreign ----(9.74M)
Income Tax Credits 19.75M30.68M25.56M-4.01M
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income (68.72M)(90M)(169.15M)(272.69M)(9.06M)
Minority Interest Expense -----
Net Income (68.72M)(90M)(169.15M)(272.69M)(9.06M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (68.72M)(90M)(169.15M)(272.69M)(9.06M)
Preferred Dividends -----
Net Income Available to Common (68.72M)(90M)(169.15M)(272.69M)(9.06M)
EPS (Basic) (3.35)(3.99)(6.69)(9.61)(0.29)
Basic Shares Outstanding 20.53M22.53M25.3M28.37M30.97M
EPS (Diluted) (3.35)(3.99)(6.69)(9.61)(0.29)
Diluted Shares Outstanding 20.53M22.53M25.3M28.37M30.97M
EBITDA (93.34M)(153.39M)(182.76M)(264.77M)(113.65M)
Copyright 2020 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Link to MarketWatch's Slice.